BG103687A - Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative processes and conditions related to the central nervous system - Google Patents
Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative processes and conditions related to the central nervous systemInfo
- Publication number
- BG103687A BG103687A BG103687A BG10368799A BG103687A BG 103687 A BG103687 A BG 103687A BG 103687 A BG103687 A BG 103687A BG 10368799 A BG10368799 A BG 10368799A BG 103687 A BG103687 A BG 103687A
- Authority
- BG
- Bulgaria
- Prior art keywords
- quinazolinones
- atropisomers
- heteroaryl
- treatment
- nervous system
- Prior art date
Links
- 210000003169 central nervous system Anatomy 0.000 title abstract 2
- 230000004770 neurodegeneration Effects 0.000 title abstract 2
- 230000006378 damage Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3854097P | 1997-02-28 | 1997-02-28 | |
PCT/IB1998/000151 WO1998038187A1 (fr) | 1997-02-28 | 1998-02-06 | Atropisomeres de 3-heteroaryl-4(3h)-quinazolinones pour le traitement des troubles neurodegeneratifs et des troubles lies a un traumatisme du systeme nerveux central |
Publications (1)
Publication Number | Publication Date |
---|---|
BG103687A true BG103687A (en) | 2000-06-30 |
Family
ID=21900535
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BG103687A BG103687A (en) | 1997-02-28 | 1999-08-24 | Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative processes and conditions related to the central nervous system |
Country Status (40)
Country | Link |
---|---|
US (1) | US6380204B1 (fr) |
EP (1) | EP0964860B1 (fr) |
JP (1) | JP3299990B2 (fr) |
KR (1) | KR20000075812A (fr) |
CN (1) | CN1248254A (fr) |
AP (1) | AP9801202A0 (fr) |
AR (1) | AR011886A1 (fr) |
AT (1) | ATE264854T1 (fr) |
AU (1) | AU732448B2 (fr) |
BG (1) | BG103687A (fr) |
BR (1) | BR9807807A (fr) |
CA (1) | CA2282279C (fr) |
CO (1) | CO4950615A1 (fr) |
DE (1) | DE69823339T2 (fr) |
DK (1) | DK0964860T3 (fr) |
DZ (1) | DZ2438A1 (fr) |
EA (1) | EA001961B1 (fr) |
ES (1) | ES2218801T3 (fr) |
GT (1) | GT199800039A (fr) |
HN (1) | HN1998000028A (fr) |
HR (1) | HRP980108B1 (fr) |
HU (1) | HUP0000935A3 (fr) |
ID (1) | ID23435A (fr) |
IL (1) | IL130897A0 (fr) |
IS (1) | IS5141A (fr) |
MA (1) | MA24485A1 (fr) |
NO (1) | NO994178L (fr) |
NZ (1) | NZ336627A (fr) |
OA (1) | OA11088A (fr) |
PA (1) | PA8446901A1 (fr) |
PE (1) | PE57999A1 (fr) |
PL (1) | PL335307A1 (fr) |
PT (1) | PT964860E (fr) |
SK (1) | SK113199A3 (fr) |
TN (1) | TNSN98034A1 (fr) |
TR (1) | TR199902094T2 (fr) |
TW (1) | TW530055B (fr) |
UA (1) | UA58536C2 (fr) |
WO (1) | WO1998038187A1 (fr) |
ZA (1) | ZA981665B (fr) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6323208B1 (en) * | 1997-09-05 | 2001-11-27 | Pfizer Inc | Atropisomers of 2,3-disubstituted-(5.6)-heteroaryl fused-pyrimidin-4-ones |
JPH11279158A (ja) * | 1998-02-09 | 1999-10-12 | Pfizer Prod Inc | キナゾリン―4―オン誘導体の製造方法 |
US6890930B1 (en) * | 1999-09-28 | 2005-05-10 | 3-Dimensional Pharmaceuticals, Inc. | Quinazolinones |
US20080146562A1 (en) * | 2003-08-08 | 2008-06-19 | Ulysses Pharmaceutical Products Inc., | Halogenated quinazolinyl nitrofurans as antibacterial agents |
BRPI0413372A (pt) * | 2003-08-08 | 2006-10-17 | Ulysses Pharmaceutical Product | composto e composições de nitrofuranos de quinazolinil halogenados, seus métodos de preparação e usos como agentes antibacterianos |
GB0416730D0 (en) | 2004-07-27 | 2004-09-01 | Novartis Ag | Organic compounds |
GB0507298D0 (en) | 2005-04-11 | 2005-05-18 | Novartis Ag | Organic compounds |
EP1954283A2 (fr) * | 2005-11-04 | 2008-08-13 | Hydra Biosciences, Inc. | Composés destinés à moduler la fonction de trpv3 |
JP2010505811A (ja) * | 2006-10-04 | 2010-02-25 | ファイザー・プロダクツ・インク | カルシウム受容体アンタゴニストとしてのピリド[4,3−d]ピリミジン−4(3H)−オン誘導体 |
WO2008140750A1 (fr) * | 2007-05-10 | 2008-11-20 | Hydra Biosciences Inc. | Composés modulant la fonction du trp v3 |
NZ595307A (en) * | 2009-03-24 | 2013-11-29 | Gilead Calistoga Llc | Atropisomers of 2-purinyl-3-tolyl-quinazolinone derivatives and methods of use |
US8846000B2 (en) | 2009-05-29 | 2014-09-30 | Merck Sharp & Dohme Corp. | Radiolabeled PDE10 inhibitors |
US9216177B2 (en) | 2011-02-28 | 2015-12-22 | Drexel University | Small molecular inhibitors of RAD51 recombinase and methods thereof |
IL295088A (en) | 2020-01-29 | 2022-09-01 | Kamari Pharma Ltd | Compounds and preparations for use in the treatment of skin disorders |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3748325A (en) * | 1970-04-06 | 1973-07-24 | Karamchand Premchand Private | Process for the preparation of quinazolinone derivatives |
US4183931A (en) * | 1977-09-08 | 1980-01-15 | Research Corporation | 2-Ketoalkyl-4(3H)-quinazolinones |
WO1992013535A1 (fr) | 1991-02-06 | 1992-08-20 | Research Corporation Technologies, Inc. | Quinazolones substituees a activite anticonvulsivante |
DE69716810T2 (de) * | 1996-05-15 | 2003-02-27 | Pfizer Inc., New York | 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one |
ES2198546T3 (es) * | 1996-05-15 | 2004-02-01 | Pfizer Inc. | 4(3h)-quinazolinonas 2,3,6 trisustituidas. |
-
1998
- 1998-02-06 WO PCT/IB1998/000151 patent/WO1998038187A1/fr not_active Application Discontinuation
- 1998-02-06 US US09/380,114 patent/US6380204B1/en not_active Expired - Fee Related
- 1998-02-06 KR KR1019997007885A patent/KR20000075812A/ko active IP Right Grant
- 1998-02-06 CA CA002282279A patent/CA2282279C/fr not_active Expired - Fee Related
- 1998-02-06 SK SK1131-99A patent/SK113199A3/sk unknown
- 1998-02-06 EA EA199900689A patent/EA001961B1/ru not_active IP Right Cessation
- 1998-02-06 TR TR1999/02094T patent/TR199902094T2/xx unknown
- 1998-02-06 DK DK98901424T patent/DK0964860T3/da active
- 1998-02-06 ES ES98901424T patent/ES2218801T3/es not_active Expired - Lifetime
- 1998-02-06 PL PL98335307A patent/PL335307A1/xx unknown
- 1998-02-06 IL IL13089798A patent/IL130897A0/xx unknown
- 1998-02-06 AU AU57759/98A patent/AU732448B2/en not_active Ceased
- 1998-02-06 PT PT98901424T patent/PT964860E/pt unknown
- 1998-02-06 JP JP53744998A patent/JP3299990B2/ja not_active Expired - Fee Related
- 1998-02-06 HU HU0000935A patent/HUP0000935A3/hu unknown
- 1998-02-06 ID IDW990935D patent/ID23435A/id unknown
- 1998-02-06 NZ NZ336627A patent/NZ336627A/xx unknown
- 1998-02-06 CN CN98802796A patent/CN1248254A/zh active Pending
- 1998-02-06 AT AT98901424T patent/ATE264854T1/de not_active IP Right Cessation
- 1998-02-06 BR BR9807807-0A patent/BR9807807A/pt not_active Application Discontinuation
- 1998-02-06 EP EP98901424A patent/EP0964860B1/fr not_active Expired - Lifetime
- 1998-02-06 DE DE69823339T patent/DE69823339T2/de not_active Expired - Fee Related
- 1998-02-09 HN HN1998000028A patent/HN1998000028A/es unknown
- 1998-02-17 PA PA19988446901A patent/PA8446901A1/es unknown
- 1998-02-19 GT GT199800039A patent/GT199800039A/es unknown
- 1998-02-23 PE PE1998000127A patent/PE57999A1/es not_active Application Discontinuation
- 1998-02-25 CO CO98010303A patent/CO4950615A1/es unknown
- 1998-02-25 DZ DZ980048A patent/DZ2438A1/fr active
- 1998-02-25 TW TW087102713A patent/TW530055B/zh not_active IP Right Cessation
- 1998-02-25 TN TNTNSN98034A patent/TNSN98034A1/fr unknown
- 1998-02-25 MA MA24979A patent/MA24485A1/fr unknown
- 1998-02-26 AR ARP980100872A patent/AR011886A1/es unknown
- 1998-02-26 AP APAP/P/1998/001202A patent/AP9801202A0/en unknown
- 1998-02-27 HR HR980108A patent/HRP980108B1/xx not_active IP Right Cessation
- 1998-02-27 ZA ZA9801665A patent/ZA981665B/xx unknown
- 1998-06-02 UA UA99084850A patent/UA58536C2/uk unknown
-
1999
- 1999-07-30 IS IS5141A patent/IS5141A/is unknown
- 1999-08-20 OA OA9900186A patent/OA11088A/fr unknown
- 1999-08-24 BG BG103687A patent/BG103687A/xx unknown
- 1999-08-27 NO NO994178A patent/NO994178L/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL267381A (en) | A pharmaceutical preparation containing dextromethorphan and quinidine for the treatment of nervous disorders | |
BG102999A (en) | New 2,3-diasubstituted-4-(3h)-quinazolinons | |
MX9707980A (es) | Derivados de 4-aminoquinazolina, composiciones que los contienen, y uso de los mismos. | |
UA66825C2 (uk) | Азаполіциклічні сполуки, конденсовані з арилом, фармацевтична композиція, спосіб лікування та спосіб зниження нікотинової залежності | |
AP9701041A0 (en) | Pyridylpyrrole compounds. | |
SI0725779T1 (fr) | ||
AU4331400A (en) | Neurotrophic substituted pyrimidines | |
BG103687A (en) | Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative processes and conditions related to the central nervous system | |
UA48946C2 (uk) | Арилалкілдіазинони, спосіб їх одержання (варіанти), фармацевтичний склад, спосіб його одержання та спосіб лікування | |
EP1032556A4 (fr) | Composes pharmaceutiquement actifs et procedes d'utilisation | |
BG105962A (en) | Use of saredutant and the pharmaceutically acceptable salts thereof to produce medicaments used to treat or prevent mood disorders, adjustment disorders or mixed anxiety-depression disorders | |
IL115589A0 (en) | Use of cck-b antagonists in pharmaceutical compositions | |
MX9707642A (es) | Uso de 2-oxoindol-1-carboxamidas 3-sustituidas y sus sales de base farmaceuticamente aceptables para preparar composiciones para el tratamiento y prevencion de la enfermedad de alzheimer en mamiferos, incluyendo a humanos. | |
UA42731C2 (uk) | Арилалкілтіадіазинони, спосіб їх отримання, фармацевтична композиція, спосіб її отримання, спосіб лікування | |
MY110149A (en) | Compounds for the treatment of neurodegenerative disorders | |
HUP0100611A2 (hu) | Triazin vegyületek, és ilyeneket tartalmazó gyógyszerkészítmények a központi idegrendszer elváltozásainak kezelésére | |
HU9502848D0 (en) | Imidazoloquinoxalinone derivatives as eaa antagonists | |
NZ533358A (en) | 3,4-Dihydro-1H-isoquinolin-2-yl-derivatives for use as NK2 receptor antagonists | |
IL143382A0 (en) | Human adult astrocytes, their preparation and uses thereof | |
BG105549A (en) | Use of n-substituted azabicycloalkane derivatives for treating diseases of the central nervous system | |
HU9701325D0 (en) | New 2,3-benzodiazepine derivatives | |
WO2004091522A3 (fr) | Procede de traitement de troubles neurodegeneratifs | |
MX9705390A (es) | Uso de los 3,4-difenil-cromanos para la fabricacion de una composicion farmaceutica para el tratamiento o profilaxis de desordenes degenerativos cerebrales. | |
MX9703610A (es) | Nuevas (5,6)-heteroaril condensado-pirimidin-4-onas 2,3 disustituidas. | |
UA33498A (uk) | Спосіб лікування терапевтично резистентних форм шизофренії |